|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash | ||||||||
| Deferred offering costs | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Cash held in Trust Account | ||||||||
| Total assets | ||||||||
| Liabilities and shareholders' deficit | ||||||||
| Current liabilities: | ||||||||
| Accrued formation and offering costs | ||||||||
| Accrued expenses, formation and offering costs | ||||||||
| Accrued professional fees and other expenses | ||||||||
| Note payable to Sponsor | ||||||||
| Deferred underwriting compensation, current portion | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting compensation | ||||||||
| Total liabilities | ||||||||
| Class A ordinary shares subject to possible redemption; 40,000,000 shares at December 31, 2021, at a redemption value of $10.00 per share | ||||||||
| Shareholders' deficit: | ||||||||
| Ordinary shares, value | ||||||||
| Class A Ordinary Shares | ||||||||
| Class F Ordinary Shares | ||||||||
| Class G Ordinary Shares | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total shareholders' deficit | ||||||||
| Total liabilities and shareholders' deficit |
Loading...
